MYC and neoplasm: Table 3 summarizes the independent univariate analyses performed for each potential prognostic factor. Ki-67 positivity >90% (p = 0.001), CD3 positivity (p = 0.002), tumor size >5 cm (p = 0.003), less than two lesions (p = 0.029), AB blood type (p = 0.011), BCL-2 and C-MYC coexpression (p = 0.036), and deep brain involvement (p = 0.017) were significantly related to a worse OS (Figures 3A, C, D, G, 4A, C).